Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FocalPoint Partners is a U.S. middle-market investment bank focused on mergers and acquisitions, private capital advisory, financial restructuring, and special situations. The firm developed industry practices across sectors including healthcare, but it is not itself a biotech, pharma, or healthcare operating company. Founded in 2002 in Los Angeles, FocalPoint built a national advisory franchise serving strategic and financial sponsor clients. In January 2022, B. Riley Financial agreed to acquire FocalPoint Securities, with reported total consideration of up to $175 million. Following the transaction, the business has continued as part of B. Riley's broader investment banking platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FocalPoint Partners.